Literature DB >> 29255643

Best of lung cancer session presented during ERS 2017 Chinese language day: lung cancer screening.

Clementine Bostantzoglou1, Chrysoula Kontogianni1, Marianthi Iliopoulou1, Mina Gaga1.   

Abstract

Entities:  

Year:  2017        PMID： 29255643      PMCID： PMC5717361          DOI： 10.21037/jtd.2017.11.42

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  16 in total

1.  Results of the Randomized Danish Lung Cancer Screening Trial with Focus on High-Risk Profiling.

Authors:  Mathilde M W Wille; Asger Dirksen; Haseem Ashraf; Zaigham Saghir; Karen S Bach; John Brodersen; Paul F Clementsen; Hanne Hansen; Klaus R Larsen; Jann Mortensen; Jakob F Rasmussen; Niels Seersholm; Birgit G Skov; Laura H Thomsen; Philip Tønnesen; Jesper H Pedersen
Journal:  Am J Respir Crit Care Med       Date:  2016-03-01       Impact factor: 21.405

2.  Prognostic assessment of 2,361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II, and IIIA.

Authors:  M T van Rens; A B de la Rivière; H R Elbers; J M van Den Bosch
Journal:  Chest       Date:  2000-02       Impact factor: 9.410

3.  Lung cancer screening with low-dose spiral computed tomography.

Authors:  S M Stephenson; K F Mech; A Sardi
Journal:  Am Surg       Date:  2005-12       Impact factor: 0.688

4.  Selection criteria for lung-cancer screening.

Authors:  Martin C Tammemägi; Hormuzd A Katki; William G Hocking; Timothy R Church; Neil Caporaso; Paul A Kvale; Anil K Chaturvedi; Gerard A Silvestri; Tom L Riley; John Commins; Christine D Berg
Journal:  N Engl J Med       Date:  2013-02-21       Impact factor: 91.245

5.  Targeting of low-dose CT screening according to the risk of lung-cancer death.

Authors:  Anil K Chaturvedi; Hormuzd A Katki; Stephanie A Kovalchik; Martin Tammemagi; Christine D Berg; Neil E Caporaso; Tom L Riley; Mary Korch; Gerard A Silvestri
Journal:  N Engl J Med       Date:  2013-07-18       Impact factor: 91.245

6.  Overstating the evidence for lung cancer screening: the International Early Lung Cancer Action Program (I-ELCAP) study.

Authors:  H Gilbert Welch; Steven Woloshin; Lisa M Schwartz; Leon Gordis; Peter C Gøtzsche; Russell Harris; Barnett S Kramer; David F Ransohoff
Journal:  Arch Intern Med       Date:  2007-11-26

7.  Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening.

Authors:  Nanda Horeweg; Joost van Rosmalen; Marjolein A Heuvelmans; Carlijn M van der Aalst; Rozemarijn Vliegenthart; Ernst Th Scholten; Kevin ten Haaf; Kristiaan Nackaerts; Jan-Willem J Lammers; Carla Weenink; Harry J Groen; Peter van Ooijen; Pim A de Jong; Geertruida H de Bock; Willem Mali; Harry J de Koning; Matthijs Oudkerk
Journal:  Lancet Oncol       Date:  2014-10-01       Impact factor: 41.316

8.  Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT.

Authors:  Andrea Lopes Pegna; Giulia Picozzi; Mario Mascalchi; Francesca Maria Carozzi; Laura Carrozzi; Camilla Comin; Cheti Spinelli; Fabio Falaschi; Michela Grazzini; Florio Innocenti; Cristina Ronchi; Eugenio Paci
Journal:  Lung Cancer       Date:  2008-08-23       Impact factor: 5.705

9.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

10.  The LLP risk model: an individual risk prediction model for lung cancer.

Authors:  A Cassidy; J P Myles; M van Tongeren; R D Page; T Liloglou; S W Duffy; J K Field
Journal:  Br J Cancer       Date:  2007-12-18       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.